Rebrand: Myeloid Therapeutics becomes CREATE Medicines, reflecting a shift to multi-lineage RNA immune programming. Scientific Focus: Expanding beyond myeloid cells to include T and NK cells for scalable, redosable in vivo CAR therapies. Clinical Data: Over 40 patients treated with … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, Science, Technology
Tagged 8VC, ARCH Venture Partners, autoimmunity, B-cell depletion, biopsies, Biotech, biotechnology, breast cancer, cancer therapy, CAR+ immune cells, CD8 T cell recruitment, clinical trials, CREATE Medicines, CREATE Medicines Bridges Science Strategy and Investment with Expanded RNA Platform for In Vivo Multi-Immune Therapies in Europe and Beyond, CREATE Medicines Integrates Scientific Progress and Investor Backing to Lead Multi-Lineage RNA Immunotherapy’s Next Chapter in Europe, CREATE Medicines Rebrand Reflects Strategic Expansion into Multi-Lineage RNA Immunotherapy as Europe’s Biotech Sector Embraces In Vivo Therapies, CREATE Medicines Reinforces Its Market and Research Focus Through RNA-Driven Multi-Lineage Immune Programming Amid Rising European Investment in mRNA Therapeutics, CREATE Medicines Strengthens Its Scientific and Strategic Position with Multi-Lineage RNA Platform and Investor Support Across a Growing European Biotech Market, CREATE Medicines’ New Identity Combines RNA-Based Scientific Leadership and Investor Momentum with Expanding Opportunities in European Immunotherapy Markets, CREATE Medicines’ Transition Marks New Phase in RNA Immunotherapy Development and Strategic Growth in Europe’s Expanding Biotech Landscape, Daniel Getts, Daniel Getts Ph.D., fibrosis, Following Its Rebrand, From Myeloid Therapeutics to CREATE Medicines: A Rebrand Uniting RNA Innovation Investor Confidence and Expanding European Immunotherapy Ambitions, GPC3, GPC3-positive solid tumors, GPC3; hepatocellular carcinoma, Hatteras Venture Partners, HER2, HER2 multi-immune CAR, HER2; solid tumors, himeric antigen receptor, immune cell reprogramming, immune cells, immune remodeling, immunotherapies, immunotherapy, in vivo CAR, in vivo CAR-T mediated B cell depletion, in vivo multi-immune programming, mRNA, mRNA-LNP platform, MT-302, MT-303, MT-304, multi-immune programming, multilineage immune programming, myeloid, myeloid cells, Myeloid Therapeutics, myeloid-focused in vivo programming, Newpath Partners, NK cell programming, NK cells, off-the-shelf therapies, oncology, Phase 1 studies, Rebranded CREATE Medicines Aligns Scientific Innovation and Investor Backing to Advance RNA-Based In Vivo CAR Therapies in Global and European Markets, Rebranded CREATE Medicines Positions Itself at the Forefront of RNA Immunotherapy as Europe’s Biotech Ecosystem Accelerates Innovation, retrotransposon-based CAR-T, RNA retrotransposon, RNA technology, RNA-based in vivo CAR therapeutics, RNA-based therapeutics, solid tumors, T cells, therapies, TROP2, TROP2; solid tumors, tumors, vivo CAR, vivo CAR-T
CREATE Medicines (“CREATE”) broadens clinical programs and capabilities to expand therapeutic potential and improve patient outcomes Therapies tolerably program immune cells inside the human body, providing clear differentiation among competitors and significant value potential for all stakeholders CREATE Medicines will … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, Science, Technology
Tagged 8VC, ARCH Venture Partners, autoimmunity, B-cell depletion, biopsies, Biotech, biotechnology, breast cancer, cancer therapy, CAR+ immune cells, CD8 T cell recruitment, clinical trials, CREATE Medicines, Daniel Getts, Daniel Getts Ph.D., fibrosis, GPC3, GPC3-positive solid tumors, GPC3; hepatocellular carcinoma, Hatteras Venture Partners, HER2, HER2 multi-immune CAR, HER2; solid tumors, immune cell reprogramming, immune cells, immune remodeling, immunotherapies, immunotherapy, in vivo CAR, in vivo CAR-T mediated B cell depletion, in vivo multi-immune programming, mRNA, mRNA-LNP platform, MT-302, MT-303, MT-304, multi-immune programming, multilineage immune programming, myeloid, myeloid cells, Myeloid Therapeutics, myeloid-focused in vivo programming, Newpath Partners, NK cell programming, NK cells, off-the-shelf therapies, oncology, Phase 1 studies, retrotransposon-based CAR-T, RNA retrotransposon, RNA technology, RNA-based in vivo CAR therapeutics, RNA-based therapeutics, solid tumors, T cells, therapies, TROP2, TROP2; solid tumors, tumors, vivo CAR, vivo CAR-T
(IN BRIEF) TU Delft, Haskoning, and the Delft University Fund have signed a new framework agreement to accelerate research on water technology and climate-resilient delta regions, supported by the Haskoning Innovation & Education Fund. The initiative will launch its first … Read the full press release
Posted in Education, Energy, Gas & Oil, Entertainment, Environment, Industrial, Netherlands, News, Science, Technology
Tagged biotechnology, circular economy, climate change, climate resilience, Delft University Fund, delta engineering, Dr Mario Pronk, flooding, Haskoning, Haskoning Innovation & Education Fund, Microplastics, Nature-based solutions, PFAS, Professor Bas Jonkman, Professor Merle de Kreuk, resource recovery, sea level rise, sustainable deltas, TU Delft, TU Delft expands long-term partnership with Haskoning to pioneer climate-resilient delta research, TU Delft launches new research initiative with Haskoning to develop sustainable solutions for global delta challenges, TU Delft partners with Haskoning and Delft University Fund to accelerate innovation in water technology and climate adaptation, water technology
(IN BRIEF) Researchers at the Karlsruhe Institute of Technology (KIT) have created a nanodroplet-based chip platform that combines drug synthesis, biological testing, and chemical analysis in a single workflow. Each droplet measures only 200 nanoliters and contains 300 cells, enabling … Read the full press release
Posted in Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged Angewandte Chemie, biotechnology, cancer research, Carsten Hopf, CeMOS, colon cancer, direct-to-biology, drug discovery, HT-29, Karlsruhe Institute of Technology, KIT, Liana Bauer, MALDI-MSI, MEK inhibitors, miniaturized workflow, mirdametinib, nanodroplet array platform, Pavel Levkin, pharmaceuticals, skin cancer, TH Mannheim
(IN BRIEF) An international team of researchers, including Empa scientists, is developing nanozymes to treat inflammation during pregnancy without harming the mother or fetus. These tiny particles, which have enzyme-like properties, could provide a safer alternative to traditional medications. Initial … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Security & Safety, Switzerland, Technology
Tagged anti-inflammatory, antibacterial, biotechnology, Empa, Empa research, fetal health, Healthcare Innovation, human placental tissue, inflammation, maternal health, nanomedicines, nanotechnology, nanozymes, Nikolaos Tagaras, placenta chip, placental barrier, pregnancy complications, pregnancy research, prenatal care, safe treatment, Swiss National Science Foundation, Tina Bürki
(IN BRIEF) NIB has financed the Gene Therapy Centre in Lithuania, a groundbreaking facility advancing gene therapy research and manufacturing. Opened in September, it is a critical part of Lithuania’s life sciences sector, contributing to the country’s goal of growing … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Finland, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Lithuania, Management, News, Pharma & Biotech, Science, Technology
Tagged BIO CITY, biotechnology, Celltechna, economic growth, gene therapy, Gene Therapy Centre, investments, life sciences, Lithuania, NIB, Nordic-Baltic region, partnership, research and manufacturing, strategic partnerships, sustainability
(IN BRIEF) WACKER and BENEO have launched 2’-Fucosyllactose (2’-FL), a human milk oligosaccharide (HMO), for early-life nutrition. Available initially in Europe, this product is part of a strategic partnership aimed at enhancing the availability of HMOs in the market. The … Read the full press release
Posted in Business, Chemicals, Environment, Financial, Food & Beverage, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology
Tagged 2’-fucosyllactose, BENEO, biotechnology, Early Life Nutrition, gut microbiota, HMO, Human Milk Oligosaccharides, immune system, infant formula, Market Growth, partnership, prebiotics, Precision Fermentation, strategic partnership, sustainability, WACKER
(IN BRIEF) Researchers from the University of Copenhagen have made a breakthrough in the biosynthetic production of Taxol, a widely used chemotherapy drug. By identifying the enzymes responsible for the final steps in the biosynthetic pathway of Taxol, the team … Read the full press release
Posted in Business, Denmark, Education, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged biosynthetic production, biotechnology, cancer treatment, chemotherapy, environmental sustainability, Feiyan Liang, ovarian cancer, Pacific yew tree, pharmaceutical innovation, Sotirios Kampranis, sustainable drug production, sustainable medicine, Taxol, University of Copenhagen
(IN BRIEF) Fraunhofer institutes have launched the BIOSYNTH project, developing a high-throughput microchip platform that uses synthetic DNA to address the growing data storage crisis. This innovative solution promises a space-saving, low-cost, and energy-efficient alternative for mass data storage, with … Read the full press release
Posted in Business, Environment, Financial, Germany, Industrial, Investment, Management, News, Science, Technology
Tagged big data technologies, Bioinformatics, BIOSYNTH project, biotechnology, data storage solutions, Fraunhofer, Hybrotec GmbH, Infineon Technologies, mass data storage, microchip platform, personalized medicine, substance screening, sustainability, synthetic biology, synthetic DNA, X-FAB Semiconductor Foundries
(IN BRIEF) Empa researchers have developed a printable, non-swelling hydrogel made from cold-water fish gelatin, enabling the creation of 3D living skin models. Designed to replicate the full complexity of human skin, including its layered architecture and cellular composition, the … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Switzerland, Technology
Tagged 3D bioprinting, artificial skin, biointerfaces, biologically compatible materials, biomimetic membranes, biotechnology, cod gelatin, cold-water fish gelatin, customized wound dressing, electrospinning, Empa, Empa Biomimetic Membranes and Textiles, Empa Laboratory for Biointerfaces, extracellular matrix, gelatin-based material, hydrogel, immune response, Kongchang Wei, Medical Innovation, non-swelling hydrogel, personalized medicine, printable hydrogel, Regenerative medicine, skin disease research, SKINTEGRITY.CH, Swiss research, synthetic skin models, Tissue Engineering, University Medicine Zurich, wound healing
(IN BRIEF) Evonik will present its expanded portfolio at PCHi 2025 in Guangzhou, showcasing advanced biotechnology and products tailored to the regional market across various sectors. The company’s Care Solutions business focuses on meeting the growing demand for eco-friendly and … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Chemicals, Environment, Financial, Germany, Government, Industrial, Investment, Management, Media, News, Science, Technology
Tagged active ingredients, air care, Alix Chen, Biosurfactants, biotechnology, care solutions, ceramide innovation, Cleansing, dermosoft® EcoLact C MB, eco-friendly products, Evonik, Golden C® NG, Guangzhou, hair care, HAIRMIMICS® Boost, household cleaning, makeup removers, PCHi 2025, personal care, Product Protection, regional market, REWOFERM® series, RHEANCE® One, skin care, SOPHANCE® LA-A, SPHINGONY® sphingolipid, sun care, sustainability, symbio®pure G3C2 MB, system solutions
(IN BRIEF) Evonik has developed a groundbreaking model of the skin microbiome that allows for realistic, scientifically validated testing of how cosmetic ingredients impact the skin’s microbial communities. This model recreates the complex interactions between microbes, providing more accurate insights … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Chemicals, Environment, Financial, Germany, Industrial, Investment, Management, News, Science, Technology
Tagged biotechnology, Cosmetics Testing, Evonik, Skin Microbiome Model, sustainability
(IN BRIEF) Kembara Fund I FCR, a €1 billion deep tech and climate-focused fund managed by Spain-based Alma Mundi Ventures, has secured a €350 million commitment from the European Investment Fund (EIF). As the first Spanish fund to be selected … Read the full press release
Posted in European Union, Financial, Investment, Luxembourg, Small Business, Spain, Technology, Telecom
Tagged AI, Alma Mundi Ventures, artificial intelligence, Atomico Growth VI, biotechnology, Capital Markets Union, capital-intensive businesses, cleantech, Climate Innovation, competitiveness, Cybersecurity, deep tech, digital technologies, digital transformation, EIF, engineering breakthroughs, ETCI, Europe, European Investment Fund, European Tech Champion Initiative, European tech champions, Factorial, financial technologies, France, frontier technologies, FSI II, Germany, growth-stage startups, Healthcare, Inke, intellectual property, Javier Santiso, Keensight Nova VI, Kembara Fund I FCR, life sciences, Marjut Falkstedt, Mundi Ventures, next-generation energy systems, public and private resources, quantum technologies, robotics, scientific breakthroughs, Space tech, Spain, Startups, strategic autonomy, Sweden, tech ecosystem, transformative ventures
(IN BRIEF) Covestro has inaugurated a groundbreaking pilot plant at its Leverkusen site, heralding a significant leap in chemical production. This innovative facility is set to produce aniline—a crucial chemical component—solely from plant biomass, departing from traditional petroleum-based methods. Aniline … Read the full press release
(IN BRIEF) Evonik has successfully completed its industrial-scale facility for sustainable biosurfactants in Slovakia, becoming the world’s first plant to produce sustainable rhamnolipid biosurfactants. These high-quality biosurfactants are manufactured through a biogenic, carbon-based fermentation process, eliminating the need for petrochemical … Read the full press release
Posted in Business, Chemicals, Construction, Education, Environment, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Management, News, Science, Slovakia, Technology
Tagged biotechnology, Evonik, facility, Johann-Caspar Gammelin, partnership, rhamnolipid biosurfactants, Slovakia, sustainability, Yann d'Hervé
(IN BRIEF) The BioSense Institute in Novi Sad has opened a new building offering modern facilities for scientific research and business ventures in the fields of agriculture and biotechnology. The €34 million project was financed by €14 million in EU … Read the full press release
Posted in Agriculture, Banks, Education, European Union, Financial, Investment, Pharma & Biotech, Science, Serbia, Small Business, Technology
Tagged agriculture, Ana Brnabić, ANTARES project, BioSense Institute, biotechnology, Branko Ružić, EIB, European Investment Bank, Felicitas Riedl, Igor Mirović, Jelena Begović, Jelena Tanasković, life sciences, Mariya Gabriel, Marko Blagojević, Mihailo Jovanović, Novi Sad, scientific research, SERBIA, Startups, Tanja Miščević, University of Novi Sad, Vladimir Crnojević, Youth Mariya Gabriel
(IN BRIEF) The Conference Forum has announced that the 7th annual European Patients as Partners® in Clinical Research conference will take place in London on June 12-13, 2023. The event will focus on achieving greater representation in clinical research, building … Read the full press release
Posted in Government, Healthcare, News, Non Profit, Pharma & Biotech, United Kingdom
Tagged 7th annual European Patients as Partners®, biotechnology, Boehringer Ingelheim, Center for BME Health, clinical development, clinical research, Clinical Research conference, clinical trials, Community Engagement, CSL Behring, Deirdre BeVard, Diversity in Clinical Research, drug development, government, Health Equity, Healthcare, Hospital, Lundbeck, Medicine Development, Medicine Lifestyle, Medicines Development, Novartis, Patient Advocacy, Patient Centricity, Patient Communities, patient engagement, Patient Perspective, Patient Recruitment, Patient Retention, Patient Voice, Patients as Partners, Pharmaceutical, research and development, Sanofi, The Conference Forum, Thistle Hotel Marble Arch, Valerie Bowling
(IN BRIEF) Bayer has announced the recipients of its 2023 Grants4Ag program, which will provide funding and mentorship to researchers working on sustainability and biotechnology in agriculture. The program will award grants ranging from €5,000 to €15,000 and connect researchers … Read the full press release
Posted in Agriculture, Awards, Business, Germany, Management, News, Pharma & Biotech, Science, Technology
Tagged agriculture, Awards, Bayer, biotechnology, Dr. Phil Taylor, grants, Grants4Ag program, innovative, mentorship, Prof. Ji Zhou, researchers, sustainability
(IN BRIEF) Researchers from the Ecole Normale Supérieure in Lyon and the University of Freiburg’s Institute of Physiology have cast doubt on the accepted model of creating electropores in biomembranes using electric fields. Electroporation is used to create targeted defects … Read the full press release
(IN BRIEF) UK Research and Innovation has launched the Biotech Business Incubation Centre (Bio BIC) in the north-west of England to support small biotech businesses. Bio BIC, a collaboration between the Biotechnology and Biological Sciences Research Council and the Science … Read the full press release
Posted in Financial, News, Science, Technology, United Kingdom
Tagged Amy Farrington, BBSRC, Bio BIC, bioscience, Biotech Business Incubation Centre, biotechnology, Dr Karen Lewis, funding, Massimo Noro, Paul Vernon, R&D, Sci-Tech Daresbury, start-ups, Steve Rotheram, STFC, UK Research and Innovation, UKRI
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?